478 related articles for article (PubMed ID: 21880806)
21. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; Hodak SP; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
Cancer; 2014 Dec; 120(23):3627-34. PubMed ID: 25209362
[TBL] [Abstract][Full Text] [Related]
22. BRAF
Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
[TBL] [Abstract][Full Text] [Related]
23. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract][Full Text] [Related]
24. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
[TBL] [Abstract][Full Text] [Related]
25. Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.
Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36744987
[TBL] [Abstract][Full Text] [Related]
26. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of NRAS codon 61 mutation analysis and core needle biopsy for the diagnosis of thyroid nodules previously diagnosed as atypia of undetermined significance.
Jang EK; Kim WG; Kim EY; Kwon H; Choi YM; Jeon MJ; Baek JH; Lee JH; Kim TY; Shong YK; Choi J; Song DE; Kim WB
Endocrine; 2016 May; 52(2):305-12. PubMed ID: 26547216
[TBL] [Abstract][Full Text] [Related]
28. Simultaneously Detection of 50 Mutations at 20 Sites in the BRAF and RAS Genes by Multiplexed Single-Nucleotide Primer Extension Assay Using Fine-Needle Aspirates of Thyroid Nodules.
Stence AA; Gailey MP; Robinson RA; Jensen CS; Ma D
Yale J Biol Med; 2015 Dec; 88(4):351-8. PubMed ID: 26604858
[TBL] [Abstract][Full Text] [Related]
29. Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
Marina M; Zatelli MC; Goldoni M; Del Rio P; Corcione L; Martorana D; Percesepe A; Bonatti F; Mozzoni P; Crociara A; Ceresini G
J Endocrinol Invest; 2021 Dec; 44(12):2635-2643. PubMed ID: 33860907
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.
Ko YS; Hwang TS; Kim JY; Choi YL; Lee SE; Han HS; Kim WS; Kim SK; Park KS
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417935
[TBL] [Abstract][Full Text] [Related]
31. Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules.
Kwon H; Kim WG; Eszlinger M; Paschke R; Song DE; Kim M; Park S; Jeon MJ; Kim TY; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2016 Dec; 31(4):586-591. PubMed ID: 27834083
[TBL] [Abstract][Full Text] [Related]
32. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
[TBL] [Abstract][Full Text] [Related]
33. American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
Wu H; Zhang B; Cai G; Li J; Gu X
PLoS One; 2019; 14(7):e0219383. PubMed ID: 31295281
[TBL] [Abstract][Full Text] [Related]
34. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
35. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.
Bardet S; Goardon N; Lequesne J; Vaur D; Ciappuccini R; Leconte A; Monpeyssen H; Saguet-Rysanek V; Clarisse B; Lasne-Cardon A; Ménégaux F; Leenhardt L; Buffet C
Endocrine; 2021 Feb; 71(2):407-417. PubMed ID: 32638211
[TBL] [Abstract][Full Text] [Related]
37. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
[TBL] [Abstract][Full Text] [Related]
38. [Fine-needle aspiration cytology of thyroid nodules: molecular diagnostics in a routine diagnostic setting].
Eszlinger M; Neustadt M; Ruschenburg I; Neumann A; Franzius C; Adam S; Bacher K; Hach A; Hammoser R; Langvogt C; Molwitz T; Paschke R
Dtsch Med Wochenschr; 2014 Mar; 139(10):476-80. PubMed ID: 24570192
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
[TBL] [Abstract][Full Text] [Related]
40. Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy.
Decaussin-Petrucci M; Descotes F; Depaepe L; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Lopez J
Cytopathology; 2017 Dec; 28(6):482-487. PubMed ID: 29094776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
